# Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

> clinical trial · VERIFIED · 2026-07-21

Status: NOT_YET_RECRUITING · Sponsor: Institute of Cancer Research, United Kingdom · Condition: Melanoma (Skin Cancer)

- Company: Institute of Cancer Research, United Kingdom
- Sector: Melanoma (Skin Cancer)
- Primary source: https://clinicaltrials.gov/study/NCT07718243

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.